See Catalyst Pharma price target based on 3 analysts offering 12 month price targets for Catalyst Pharma in the last 3 months. The average price target is $8.33 with Filter CPRX News Items All News Types Featured Stories Commentary Downgrade Earnings Hedge Fund Mgmt Change New Coverage (Bullish) Product News PT Lowered PT Raised PT Set (Bullish) Rating Reiterated (Bullish) Resumes Coverage (Bullish) Stock Offering CPRX / Catalyst Pharmaceuticals, Inc. 424B5 - Prospectus - 424B5 11-01 sec.gov 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-193699 The information in this prospectus supplement and the accompanying prospectus is not complete and may be changed.

4 Aug 2019 Catalyst Pharmaceuticals (CPRX) - 8:30 AM. Celcuity Inc. (CELC) - 4:30 PM. Corbus Pharmaceuticals (CRBP) - 8:30 AM. Corindus (CVRS)  StockTwits activity spike ? Halt ? Resume ? Running up now ? Running down now ? Running up ? Running down ? Running up (intermediate) ? Running down  19 Dec 2019 Equities research analysts predict that Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) will post sales of $34.21 million for the current fiscal  16 Dec 2019 Bicycle Therapeutics (NASDAQ:BCYC) and Catalyst Pharmaceuticals (NASDAQ:CPRX) are both small-cap medical companies, but which is 

With the recent gains seen out of ARCA Biopharma (Nasdaq: ABIO) (Full ABIO Report Here), investors are starting to look for other investment opportunities in the cardiovascular space.

11/12/2019 · Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock quote, history, news and other vital information to help you with your stock trading and investing. Catalyst Pharmaceutical (CPRX) Beats Q3 Earnings Estimates Catalyst (CPRX) delivered earnings and revenue surprises of 18.18% and -8.51%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock? Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Stocktwits is the largest social network for finance. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Stock quote and company snapshot for CATALYST PHARMACEUTICALS INC (CPRX), including profile, stock chart, recent news and events, analyst opinions, and research reports. 12/23/2019 · Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

What are top-rated research analysts are saying about Catalyst Pharmaceuticals (NASDAQ:CPRX)? View CPRX's most recent analyst ratings, analyst estimates 

8/1/1985 · CPRX Catalyst Pharmaceuticals, Inc. Common Stock. Data is currently not available. DATA AS OF Dec 12, 2019 5:36 PM ET - AFTER HOURS. $4.40 0.08 1.85%. Are you trading options on Catalyst Pharmaceuticals (NASDAQ:CPRX)? View CPRX's options chain, put prices and call prices at MarketBeat. Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. 11/29/2018 · Why Catalyst Pharmaceuticals Stock Is Sinking Today Catalysts' landmark FDA approval wasn't enough to convince investors to stay the course.

CPRX / Catalyst Pharmaceuticals, Inc. 424B5 - Prospectus - 424B5 11-01 sec.gov 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-193699 The information in this prospectus supplement and the accompanying prospectus is not complete and may be changed.

Get breaking news and analysis on Catalyst Pharmaceuticals, Inc. (CPRX) stock, price quote and chart, trading and investing tools.

Analyzing AssetMark Financial (NYSE:AMK) stock? View AMK's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat.

CPRX | Complete Catalyst Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Technical stock forecast for CPRX: Catalyst Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still  Researching Catalyst Pharmaceuticals (NASDAQ:CPRX) stock? View CPRX's stock price, price target, earnings, financials, forecast, insider trades, news, and  What are top-rated research analysts are saying about Catalyst Pharmaceuticals (NASDAQ:CPRX)? View CPRX's most recent analyst ratings, analyst estimates 

29 Nov 2019 Shares of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) shot up 7.1% during trading on Wednesday . The company traded as high as $4.83  Real-time trade and investing ideas on Catalyst Pharmaceutical Partners Inc. CPRX from the largest community of traders and investors. ©2019 StockTwits, Inc. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. The latest messages and market ideas from @CPRX80 on Stocktwits. The largest community for investors and traders